These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3531574

  • 21. [Beta-lactamase inhibitors. I. In vivo evaluation of an amoxicillin + clavulanic acid combination in the treatment of urinary infections].
    Dalet F, Del Río G.
    Rev Clin Esp; 1984 Feb 15; 172(3):153-7. PubMed ID: 6609385
    [No Abstract] [Full Text] [Related]

  • 22. [Pediatric suspensions of amoxicillin and clavulanic acid in the treatment of bacterial infections of otorhinolaryngologic importance and the upper respiratory tract].
    Amendola F, Natuzzi M, De Mattia D, Schettini F.
    Minerva Pediatr; 1989 Feb 15; 41(2):97-103. PubMed ID: 2786988
    [Abstract] [Full Text] [Related]

  • 23. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar 15; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 24. [Clinical application of beta-lactamase inhibitors on urinary tract infections].
    Ohkawa M.
    Nihon Rinsho; 1986 Dec 15; 44(12):2573-7. PubMed ID: 3029463
    [No Abstract] [Full Text] [Related]

  • 25. Respiratory tract infections caused by beta-lactamase producing organisms treated with augmentin.
    Mehtar S.
    Scott Med J; 1982 Dec 15; 27 Spec No.():S24-7. PubMed ID: 6984777
    [Abstract] [Full Text] [Related]

  • 26. Changing role of co-trimoxazole in the treatment of recurrent urinary infections: a comparison with augmentin.
    Brumfitt W, Hamilton-Miller JM.
    Br J Clin Pract; 1985 Sep 15; 39(9):346-51. PubMed ID: 3904797
    [No Abstract] [Full Text] [Related]

  • 27. The efficacy of augmentin as a beta-lactam antibiotic in surgical and medical practice.
    Kirei BR, Mhalu FS, Pallangyo PK, Seif SA.
    East Afr Med J; 1987 Jul 15; 64(7):499-503. PubMed ID: 3691365
    [No Abstract] [Full Text] [Related]

  • 28. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC, Barry AL.
    J Reprod Med; 1990 Mar 15; 35(3 Suppl):317-21. PubMed ID: 2319514
    [Abstract] [Full Text] [Related]

  • 29. [Comparative study of BRL28500 (clavulanic acid-ticarcillin) and ticarcillin in the treatment of respiratory tract infections].
    Miki F, Ikuno Y, Inoue E, Murata A, Tanizawa S, Sakamoto K, Tahara A, Saito A, Tomizawa M, Hiraga Y.
    Kansenshogaku Zasshi; 1987 Aug 15; 61(8):944-79. PubMed ID: 3125285
    [No Abstract] [Full Text] [Related]

  • 30. Further data on augmentin and co-trimoxazole in the treatment of urinary tract infection.
    Matts SG, Fancourt GJ, Mitchell CJ, Gowers E, Boston PF.
    Br J Clin Pract; 1985 May 15; 39(5):179-84. PubMed ID: 3907682
    [No Abstract] [Full Text] [Related]

  • 31. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Hou F, Li J, Gao L, Chen Y.
    Chin Med J (Engl); 1998 Nov 15; 111(11):1039-43. PubMed ID: 11189212
    [Abstract] [Full Text] [Related]

  • 32. Extended release amoxicillin/clavulanate: optimizing a product for respiratory infections based on pharmacodynamic principles.
    Jacobs MR.
    Expert Rev Anti Infect Ther; 2005 Jun 15; 3(3):353-60. PubMed ID: 15954852
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral formulations as well as in body fluids and tissue homogenates. Comparison of sulbactam, clavulanic acid, ampicillin and amoxicillin].
    Wildfeuer A, Räder K.
    Arzneimittelforschung; 1991 Jan 15; 41(1):70-3. PubMed ID: 2049115
    [Abstract] [Full Text] [Related]

  • 35. Treatment of obstetric and gynecologic infections, with an emphasis on beta-lactamase-producing organisms.
    McGregor JA, Christiansen FB.
    J Reprod Med; 1988 Jun 15; 33(6 Suppl):591-4. PubMed ID: 3294404
    [Abstract] [Full Text] [Related]

  • 36. Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.
    Weber DJ, Tolkoff-Rubin NE, Rubin RH.
    Pharmacotherapy; 1984 Jun 15; 4(3):122-36. PubMed ID: 6739312
    [Abstract] [Full Text] [Related]

  • 37. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP.
    Antibiot Khimioter; 1997 Jun 15; 42(12):29-32. PubMed ID: 9480651
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ticarcillin disodium and clavulanate potassium in the treatment of post-cesarean-section endomyometritis.
    Sanders CV, Pastorek JG, Miller JM, Aldridge KE.
    J Reprod Med; 1988 Jun 15; 33(6 Suppl):584-7. PubMed ID: 3260949
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.